Interleukin Genetics, Inc. (OTCQB:ILIU) today announced financial and operational results for the third fiscal quarter ended September 30, 2014.
“During the third quarter, we gained additional visibility and positive recognition among important influencers in dentistry and molecular diagnostics by participating in several key conferences, including the American Dental Association annual meeting, the American Academy of Periodontology annual meeting and the BTIG Inaugural Emerging Technologies in Healthcare Diagnostics Symposium,” said Dr. Kenneth Kornman, Chief Executive Officer of Interleukin Genetics.
Help employers find you! Check out all the jobs and post your resume.
